These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7749362)

  • 41. Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme.
    Collier JG; Robinson BF; Vane JR
    Lancet; 1973 Jan; 1(7794):72-4. PubMed ID: 4118651
    [No Abstract]   [Full Text] [Related]  

  • 42. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bothrops jararaca venom gland transcriptome: analysis of the gene expression pattern.
    Cidade DA; Simão TA; Dávila AM; Wagner G; Junqueira-de-Azevedo IL; Ho PL; Bon C; Zingali RB; Albano RM
    Toxicon; 2006 Sep; 48(4):437-61. PubMed ID: 16905169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Presence of functional angiotensin II receptor and angiotensin converting enzyme in the aorta of the snake Bothrops jararaca.
    Esteves CA; Burckhardt PL; Breno MC
    Life Sci; 2012 Nov; 91(19-20):944-50. PubMed ID: 23000029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin-degrading serine peptidase: a new chymotrypsin-like activity in the venom of Bothrops jararaca partially blocked by the commercial antivenom.
    Kuniyoshi AK; Rocha M; Cajado Carvalho D; Juliano MA; Juliano Neto L; Tambourgi DV; Portaro FC
    Toxicon; 2012 Jan; 59(1):124-31. PubMed ID: 22093545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
    van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
    Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological evidence for a presynaptic action of venoms from Bothrops insularis (jararaca ilhoa) and Bothrops neuwiedi (jararaca pintada).
    Rodrigues-Simioni L; Zamunér SR; Cogo JC; Borja-Oliveira CR; Prado-Franceschi J; da Cruz-Höfling MA; Corrado AP
    Toxicon; 2004 May; 43(6):633-8. PubMed ID: 15109884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biological and immunological properties of the venom of Bothrops alcatraz, an endemic species of pitviper from Brazil.
    Furtado MF
    Comp Biochem Physiol C Toxicol Pharmacol; 2005 Jun; 141(2):117-23. PubMed ID: 16002343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical and pharmacological aspects of two bradykinin-potentiating peptides obtained from tryptic hydrolysis of casein.
    Perpetuo EA; Juliano L; Lebrun I
    J Protein Chem; 2003 Nov; 22(7-8):601-6. PubMed ID: 14714726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the effects of angiotensin-converting enzyme inhibitors with bradykinin, angiotensin II and their specific antagonists on concanavalin A-induced proliferation of mouse T-lymphocytes.
    Yeung JH
    Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):163-72. PubMed ID: 8046949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype.
    van Esch JH; van Gool JM; de Bruin RJ; Payne JR; Montgomery HE; Hectors M; Deinum J; Dive V; Jan Danser AH
    J Hypertens; 2008 Apr; 26(4):706-13. PubMed ID: 18327080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a fast liquid chromatography/mass spectrometry screening method for angiotensin-converting enzyme (ACE) inhibitors in complex natural mixtures like snake venom.
    Siemerink M; Schebb NH; Liesener A; Perchuc AM; Schöni R; Wilmer M; Hayen H; Karst U; Vogel M
    Rapid Commun Mass Spectrom; 2010 Mar; 24(5):687-97. PubMed ID: 20162537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Jararhagin, a hemorrhagic snake venom metalloproteinase from Bothrops jararaca.
    Moura-da-Silva AM; Baldo C
    Toxicon; 2012 Sep; 60(3):280-9. PubMed ID: 22534074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bradykinin and inhibition of angiotensin-converting enzyme in hypertension.
    Agarwal R
    N Engl J Med; 1999 Mar; 340(12):967-8; author reply 968-9. PubMed ID: 10094649
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom.
    Greene LJ; Camargo AC; Krieger EM; Stewart JM; Ferreira SH
    Circ Res; 1972 Sep; 31(9):Suppl 2:62-71. PubMed ID: 4341481
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of a bradykinin potentiating nonapeptide (BPP9a) on prolonged haemorrhagic shock in dogs.
    Errington ML; Rocha e Silva Júnior M
    J Physiol; 1973 Aug; 233(1):46P-47P. PubMed ID: 4357201
    [No Abstract]   [Full Text] [Related]  

  • 57. A natural carrier effect and the generation of specific antibodies to biologically active peptides.
    Tsuruta LR; Hayashi MA; Konno K; Tambourgi DV; Assakura MT; Camargo AC; Sant'Anna OA
    Anal Biochem; 2006 Jun; 353(2):174-80. PubMed ID: 16624244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New aspects on inflammatory reactions and cough following inhibiton of angiotensin converting enzyme.
    Lindgren BR
    Acta Physiol Scand Suppl; 1988; 573():1-60. PubMed ID: 2466391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease.
    Messadi E
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the neurotoxic and myotoxic effects of Brazilian Bothrops venoms and their neutralization by commercial antivenom.
    Zamunér SR; da Cruz-Höfling MA; Corrado AP; Hyslop S; Rodrigues-Simioni L
    Toxicon; 2004 Sep; 44(3):259-71. PubMed ID: 15302532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.